openPR Logo
Press release

Next-Generation Antibody Therapeutics Market : Moving Towards a Brighter Future - Top Key Players are Pfizer, Amgen, Biogen, Bristol-Myers Squibb Company, Xencor Inc, Bayer AG

11-12-2018 07:49 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Next-Generation Antibody Therapeutics Market : Moving Towards

The global next-generation antibody therapeutics market is growing due to increasing popularity of antibody-drug conjugate (ADC) and increasing number of collaborations for R&D in next-generation antibody therapeutics. In addition, growing prevalence of chronic diseases and increase in research and development investments by various organizations for production of improved products further encourages the growth of global next-generation antibody therapeutics market. Furthermore, increase in healthcare expenditure and technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, which is resulting in increased demand for next-generation antibody therapeutics.

Browse report sample at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample

Governments of various countries are involved in taking initiatives for improving healthcare facilities, and making next-generation antibody therapeutics affordable. This is increasing the demand for next-generation antibody therapeutics. The increasing global gross domestic product (GDP) and growing healthcare expenditure have created a positive impact on the growth of the next-generation antibody therapeutics market. Also, in comparison to traditional antibodies, the next-generation antibody therapeutics is more effective in the treatment of various diseases, such as cancer, autoimmune disorders, and inflammatory diseases. This is attracting various pharmaceutical and biotechnology companies to increase their investment in the R&D of next-generation antibody therapeutics.

Browse report at: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market

However, certain restraints such as high cost of next-generation antibody therapeutics, stringent regulatory requirements and time-consuming approval process for new drugs are hindering the market growth. North America next-generation antibody therapeutics market is expected to witness the fastest growth of CAGR 46.2% globally, during the period 2015 – 2020.

NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET SEGMENTATION
Next-Generation antibody therapeutics market by therapeutic area
• Oncology
• Autoimmune/Inflammatory
Next-Generation antibody therapeutics market by technology
• Antibody Drug Conjugates (ADCs)
• Bispecific Antibodies (BsAbs)
• Fc Engineered Antibodies
• Antibody Fragments and Antibody-like Proteins (AF & ALPs)
• Biosimilar Antibody (Ab) products
NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET BREAKDOWN BY GEOGRAPHY
• North America – U.S., and Rest of North America
• Europe – Germany, France, U.K., and Rest of Europe
• Asia-Pacific – Japan, and Rest of Asia-Pacific
• Rest of the World (RoW)

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next-Generation Antibody Therapeutics Market : Moving Towards a Brighter Future - Top Key Players are Pfizer, Amgen, Biogen, Bristol-Myers Squibb Company, Xencor Inc, Bayer AG here

News-ID: 1363221 • Views:

More Releases from P&S Intelligence

Remote Access Provided by Cloud Category Fuels Call Center AI Market
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media. In order to pace up the 4th industrial revolution, businesses across various industries
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Market
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG. North America will grow the fastest with a rate of 10.5% in
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Market
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use. Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls
North America, the Largest Revenue Producer in Public Safety and Security Market
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities

All 5 Releases


More Releases for Antibody

Antibody Engineering Services Market Size, Share | Industry Report, 2021-2027| F …
Complete study of the global Antibody Engineering Services market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Antibody Engineering Services industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for
Monoclonal Antibody Custom Service Market Ravishing Growth with CAGR of 10.84% | …
Complete Study of Monoclonal Antibody Custom Service Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa. Avail Premium Sample Copy @ https://www.marketresearchfuture.com/sample_request/4515 Monoclonal Antibody Custom Service Market – Overview It is estimated that monoclonal antibody custom service market is expected to
Global In-depth analysis and Growth of Market Study on Combination Antibody Ther …
"Global Market Study on Combination Antibody Therapy: Antibody/Antibody Combination Segment Expected to Dominate the Global Market Through 2024" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. .
Procalcitonin Antibody Market
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E.coli Scope of the Report: This report focuses on the Procalcitonin
Cancer Antibody Drug Conjugates Market Cancer Antibody Drug Conjugates Clinical …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Impetus of Antibody Drug Conjugates 1.1 Prologue to Cancer Antibody Drug Conjugate 1.2 The ABCs of ADCs Structural Entities of Antibody Drug Conjugate 2.1 Rational Design of Antibody Drug Conjugates 2.1.1 Monoclonal Antibody 2.1.2 Linker 2.1.3 Drug Payload 2.2 Aspects of Conjugational Chemistry Revolutionizing Antibody Drug Conjugates Generation